FDA Clears ' Day One ' Aristada Regimen for Treating Schizophrenia FDA Clears ' Day One ' Aristada Regimen for Treating Schizophrenia

The FDA has cleared an extended-release injectable version of aripiprazole lauroxil, making it the ' first and only long-acting atypical antipsychotic that can be initiated on day one, ' say researchers.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news